Literature DB >> 16969104

Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase.

Eva Petermann1, Keith W Caldecott.   

Abstract

If cells are treated with DNA damaging agents or inhibitors that interfere with ongoing DNA replication, the intra-S and S/M checkpoints delay progression through S phase and mitotic entry, respectively, to allow time for DNA repair and replication restart. In vertebrates, these checkpoint responses to replication blocks are largely mediated by the sensor kinase ATR and its major downstream effector kinase Chk1. Increasing evidence suggests that the ATR pathway is also vital in the absence of exogenous stresses, i.e., during "unperturbed" replication. Both ATR and Chk1 are essential proteins in vertebrates, and lack of components of the ATR/Chk1 pathway can result in impaired replication and spontaneous DNA damage. Here we give an overview of how the ATR/Chk1 pathway responds to exogenously blocked replication and then describe evidence for roles of this pathway during replication in an unperturbed S phase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969104     DOI: 10.4161/cc.5.19.3256

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  58 in total

1.  RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma.

Authors:  Kristina A Cole; Jonathan Huggins; Michael Laquaglia; Chase E Hulderman; Mike R Russell; Kristopher Bosse; Sharon J Diskin; Edward F Attiyeh; Rachel Sennett; Geoffrey Norris; Marci Laudenslager; Andrew C Wood; Patrick A Mayes; Jayanti Jagannathan; Cynthia Winter; Yael P Mosse; John M Maris
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-02       Impact factor: 11.205

2.  Isothiocyanate E-4IB induces MAPK activation, delayed cell cycle transition and apoptosis.

Authors:  J Bodo; J Duraj; J Jakubikova; J Sedlak
Journal:  Cell Prolif       Date:  2007-06       Impact factor: 6.831

3.  A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint.

Authors:  Rachel Beckerman; Aaron J Donner; Melissa Mattia; Melissa J Peart; James L Manley; Joaquin M Espinosa; Carol Prives
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

Review 4.  [Regulation of DNA replication timing].

Authors:  T D Kolesnikova
Journal:  Mol Biol (Mosk)       Date:  2013 Jan-Feb

5.  Chk1-cyclin A/Cdk1 axis regulates origin firing programs in mammals.

Authors:  Makoto Nakanishi; Yuko Katsuno; Hiroyuki Niida; Hiroshi Murakami; Midori Shimada
Journal:  Chromosome Res       Date:  2010-01       Impact factor: 5.239

6.  VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling.

Authors:  Sandrine Passemard; Vincent El Ghouzzi; Hala Nasser; Catherine Verney; Guilan Vodjdani; Adrien Lacaud; Sophie Lebon; Marc Laburthe; Patrick Robberecht; Jeannette Nardelli; Shyamala Mani; Alain Verloes; Pierre Gressens; Vincent Lelièvre
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

7.  Human Translesion Polymerase κ Exhibits Enhanced Activity and Reduced Fidelity Two Nucleotides from G-Quadruplex DNA.

Authors:  Sarah Eddy; Magdalena Tillman; Leena Maddukuri; Amit Ketkar; Maroof K Zafar; Robert L Eoff
Journal:  Biochemistry       Date:  2016-09-07       Impact factor: 3.162

8.  Downregulation of Wip1 phosphatase modulates the cellular threshold of DNA damage signaling in mitosis.

Authors:  Libor Macurek; Jan Benada; Erik Müllers; Vincentius A Halim; Kateřina Krejčíková; Kamila Burdová; Sona Pecháčková; Zdeněk Hodný; Arne Lindqvist; René H Medema; Jiri Bartek
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

Review 9.  Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas.

Authors:  Samir Parekh; Gilbert Privé; Ari Melnick
Journal:  Leuk Lymphoma       Date:  2008-05

10.  Jnk2 effects on tumor development, genetic instability and replicative stress in an oncogene-driven mouse mammary tumor model.

Authors:  Peila Chen; Jamye F O'Neal; Nancy D Ebelt; Michael A Cantrell; Shreya Mitra; Azadeh Nasrazadani; Tracy L Vandenbroek; Lynn E Heasley; Carla L Van Den Berg
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.